Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 20:345:e7570.
doi: 10.1136/bmj.e7570.

Sharing of clinical trial data among trialists: a cross sectional survey

Affiliations

Sharing of clinical trial data among trialists: a cross sectional survey

Vinay Rathi et al. BMJ. .

Abstract

Objective: To investigate clinical trialists' opinions and experiences of sharing of clinical trial data with investigators who are not directly collaborating with the research team.

Design and setting: Cross sectional, web based survey.

Participants: Clinical trialists who were corresponding authors of clinical trials published in 2010 or 2011 in one of six general medical journals with the highest impact factor in 2011.

Main outcome measures: Support for and prevalence of data sharing through data repositories and in response to individual requests, concerns with data sharing through repositories, and reasons for granting or denying requests.

Results: Of 683 potential respondents, 317 completed the survey (response rate 46%). In principle, 236 (74%) thought that sharing de-identified data through data repositories should be required, and 229 (72%) thought that investigators should be required to share de-identified data in response to individual requests. In practice, only 56 (18%) indicated that they were required by the trial funder to deposit the trial data in a repository; of these 32 (57%) had done so. In all, 149 respondents (47%) had received an individual request to share their clinical trial data; of these, 115 (77%) had granted and 56 (38%) had denied at least one request. Respondents' most common concerns about data sharing were related to appropriate data use, investigator or funder interests, and protection of research subjects.

Conclusions: We found strong support for sharing clinical trial data among corresponding authors of recently published trials in high impact general medical journals who responded to our survey, including a willingness to share data, although several practical concerns were identified.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CPG, HMK, and JSR receive research support from Medtronic to develop methods to promote data sharing; CPG and JSR are on a scientific advisory board for FAIR Health, a not-for-profit organisation with the mission to achieve fairness and transparency in healthcare reimbursement; HMK chairs a scientific advisory board for UnitedHealthcare, a health insurance company; SJ is a paid member of a data monitoring committee for Genzyme/Sanofi; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None
Fig 1 Flow chart showing identification and selection of potential survey respondents
None
Fig 2 Major and minor concerns with data sharing through repositories described by 317 survey respondents, grouped by overarching concern related to appropriate data use, investigator or funder interests, and protection of research subjects. (The sample number for each overarching category indicates the number of respondents who initially selected that category and were then given the opportunity to select more detailed concerns from among multiple choice responses)
None
Fig 3 Reasons for granting individual requests to share data described by 317 survey respondents, grouped by overarching reason related to promoting open science, enhancing academic benefit or recognition, and satisfying administrative requirements. (The sample number for each overarching category indicates the number of respondents who initially selected that category and were then given the opportunity to select more detailed reasons from among multiple choice responses)
None
Fig 4 Reasons for denying individual requests to share data described by 317 survey respondents, grouped by overarching reason related to ensuring appropriate data use, protecting investigator or funder interests, and protecting research subjects. (The sample number for each overarching category indicates the number of respondents who initially selected that category and were then given the opportunity to select more detailed reasons from among multiple choice responses)

Comment in

Similar articles

Cited by

References

    1. Gotzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011;12:249. - PMC - PubMed
    1. National Institutes of Health (NIH). Final NIH statement on sharing research data. 2003. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html (accessed 6 Oct 2012).
    1. Medical Research Council (MRC). MRC policy on research data-sharing. www.mrc.ac.uk/Ourresearch/Ethicsresearchguidance/datasharing/Policy/inde... (accessed 6 Oct 2012).
    1. Bill and Melinda Gates Foundation. Our commitment to sharing information. www.gatesfoundation.org/global-health/Pages/our-commitment.aspx (accessed 6 Oct 2012).
    1. Laine C, Goodman SN, Griswold ME, Sox HC. Reproducible research: moving toward research the public can really trust. Ann Intern Med 2007;146:450-3. - PubMed

Publication types

MeSH terms